Cone Health | Strategic Alliance Partners

Critically ill patients treated with a pharmacist-managed insulin protocol achieved higher rates of glucose control than those treated with conventional methods.

Pharmacy leaders from Cone Health discuss how robotic compounding technologies have improved safety, accuracy, and reliability in hazardous and sterile medication preparation across oncology and acute care settings.

Implementation of a guidance document for periprocedural antibiotic prophylaxis resulted in improved appropriateness of antibiotic dose, selection, and duration for interventional radiology procedures.

Additionally, the high cost of the cell therapy raises concerns for broader access.

The diabetes/weight loss drug has surged in popularity, and new trials are evaluating it for certain pediatric patients.

The diabetes/weight loss drug is be evaluated in trials for pediatric patients who are at least 10 years of age.

A growing number of adult and pediatric patients are being diagnosed with type 2 diabetes, despite increases in care modalities.

Nick Gazda, PharmD, MS, BCPS, CSP assistant director of Specialty Pharmacy Services, discusses how the pharmacy landscape is constantly changing, leading pharmacists to remain nimble and open.

Pharmacy Times® announces the addition of six new partners to its Strategic Alliance Partnership program.